Latest Market News

Syntara Limited has unveiled encouraging interim Phase 2a data for SNT-5505, an add-on therapy targeting myelofibrosis patients with suboptimal response to ruxolitinib. The data highlight meaningful symptom relief and spleen volume reduction, positioning the drug as a potential game-changer in a challenging treatment landscape.

Juno Minerals has agreed to sell its Mount Mason DSO Hematite Project to Gold Valley Yilgarn for A$6 million plus a 2% royalty, unlocking cash and future income while focusing on its flagship Mount Ida Magnetite Project.

EQ Resources reports promising preliminary results from tungsten stockpile testing at Wolfram Camp, achieving an 86% recovery rate using advanced X-ray sorting technology. The company is advancing plans for a regional tungsten hub to enhance operational efficiency and sustainability.

WCM Global Growth Limited has renewed its on-market share buy-back program for 12 months, signaling ongoing confidence in its capital management strategy amid evolving market conditions.

NH3 Clean Energy reports strong Pre-FEED results for its WAH2 clean ammonia project, highlighting robust economics and strategic partnerships while facing key risks around gas supply and funding.

Ioneer Ltd has raised approximately US$16 million through a strongly supported placement to advance its Rhyolite Ridge Lithium-Boron Project, complemented by a Share Purchase Plan targeting an additional US$3.3 million. This funding is pivotal for progressing environmental permitting, project readiness, and strategic partnerships.

Invion Limited launches a Loyalty Option entitlement offer aimed at raising up to $16 million to support its advancing cancer clinical trials, including a promising anogenital cancer study with Peter MacCallum Cancer Centre.

EDU Holdings reports a remarkable 118% increase in total student enrolments at its Ikon Institute for Trimester 2, 2025, driven by strong demand and new course offerings amid a shifting regulatory landscape.

New World Resources has successfully completed a placement of 32 million shares at $0.02 each to its board and senior management, following shareholder approval. This move subtly reshapes the company’s capital structure ahead of its copper and base metals projects in the US.

Saunders International announces the planned resignation of CEO Mark Benson by year-end alongside a notable downgrade in FY25 revenue and earnings guidance due to project delays and weather disruptions.

CLINUVEL Pharmaceuticals announces the full-time return of Managing Director Dr Philippe Wolgen, focusing on advancing critical product development and corporate initiatives, while Acting CEO Lachlan Hay continues until September 2025.

Thrive Tribe Technologies has announced a proposed 20, 1 share consolidation aimed at streamlining its capital structure, pending shareholder approval at the upcoming Extraordinary General Meeting.